Vislielākais burtu izmērs
Lielāks burtu izmērs
Burtu standarta izmērs
ABSTRACT GUIDELINES
Last Update
05.09.2017

The International Scientific Programme Committee invites you to submit abstracts for poster presentations at the ‘2nd International conference in Pharmacology: from cellular processes to drug targets’. The abstracts will be accepted on a range of topics related to pharmacological research.

Abstracts of the conference will be published as a supplement issue of the Journal Intrinsic Activity (2017, vol. 5 (Suppl. 2)). Each abstract will be published both as HTML and PDF version including an individual DOI. A PDF file of the entire supplement with all abstracts of the conference will be provided during the conference.

 

GUIDELINES FOR SUBMISSION AND ACCEPTANCE OF ABSTRACTS

Before abstract submission you must register for the conference.

Deadline for submission: September 25, 2017.

Abstracts may not be updated after final submission.

 

Notification of acceptance decision will be sent via email by October 5, 2017.

If you do not receive a confirmation e-mail, or for assistance on abstract submission, please contact Conference Secretariat: ICP2017RIGA@gmail.com

Please read the submission guidelines before submitting the abstract. 

Guidelines for Preparation of Abstracts
  • Only abstracts in clear English will be accepted. Please ensure that the abstract does not contain spelling, grammar or scientific errors and is of a quality suitable for publication.
  • Greek characters or special symbols may be used. Please pay attention and check carefully the final text of the abstract before submission.
  • Abstracts must be submitted online
  • The presenting author must be listed as the first author and is required to ensure that all co-authors accept the content of the abstract before submission. 
  • The presenting author must be a registered participant. Please, ensure that the presenting author’s name on the abstract matches the name submitted for conference registration.
  • Submitted abstracts should include un-published results.
  • Abstracts must be submitted in Times New Roman font with single line spacing and justified text. Abstract Body (Background, Objectives, Methods, Results, Conclusions): a maximum of 350 words.
  • Abstracts should be saved and uploaded in .docx (Word format)
  • Receptor and ion channel nomenclature should follow the official IUPHAR nomenclature, please see: http://www.guidetopharmacology.org
 
ABSTRACTS SHOULD CONTAIN THE FOLLOWING INFORMATION
  • Title:  Please choose a title that clearly indicates the content of the contribution. Avoid abbreviations. The title is limited to 25 words (in bold, Sentence case, font size 14)
  • Author(s) name(s): full first name and uppercase family name should be stated in font size 12. Do not include degrees or titles.  
  • Author’s affiliations: mentioned below author names, numbered (in italics, font size 10). Number should be put after author’s surname without spacing and in superscript. Include the name of the department, institute/university, city and country.
  • Presenting/corresponding author's: name and family name of presenting author should be marked with Asterisk (*). Full postal address and e-mail address of the corresponding author should be mentioned.

Please include the following sections: Background, Objectives, Methods, Results, Conclusions, Acknowledgments, Keywords, References in font size 12, Times New Roman, justified text.

  • Abstract Body, including Background, Objectives, Methods, Results, Conclusions should not exceed a maximum of 350 words.
  • Acknowledgements.
  • Keywords: up to 5 keywords, separated by commas.
  • References: should be indicated by numbers in brackets: [1] or [1,2] in the 'Abstract Body' section. A maximum of four references is allowed.

Please give a full citation at the end of the ‘Abstract body’ in a separate paragraph named ‘References’ (e.g., 1. Name N et al.: Journal name, Year, Volume, page numbers) in the following style:

1. Sha L., Linden DR, Farrugia G, Szursewski JH: Hydrogen suffide selectively potentiates central preganglionic fast nicotinic synaptic input in mouse mesenteric ganglio. J Neurosci, 2013; 31(31):12638-12646. doi:10.1523/JNEUROSCI.4429-12.2013

2. Pesaresi M, Soon-Shiong R, French L, Kaplan DR, Miller FD, Paus T: Axon diameter and axonal transport: in vivo and in vitro effects of androgens. Neuroimage, 2015; 115:191-202. doi:10.1016/j.neuroimage.2015.04.048

 

Please prepare your abstract strictly according to this template (download).
 


Corresponding/Presenting author

In case of successful abstract submission, you will see the following text: "Thank you for abstract submission to the 2nd International Conference in Pharmacology 'From Cellular Processes to Drug Targets'". Notification of acceptance decision will be sent via email to the corresponding author by October 5, 2017. Note: you must be registered participant for the conference by October 1, 2017.

ABSTRACT SELECTION

The Programme Committee will review all submitted abstracts. The organisers reserve the right to reject an abstract that is incorrectly written. Authors may be required to modify their abstract. If you submit an abstract to be considered for the Young Investigator Poster Award​, please ensure that you have submitted all relevant supporting documentation. Requirements for the award applicants are: less than 35 years of age at the opening date of the Conference, a copy of the document as a proof of age (passport or ID card). The applicant must be the presenting author attending the Conference.